Ultime notizie per Sterling Bancorp (NASDAQ:SBT) Azioni

Sterling Bancorp

Sterling Bancorp Inc is a unitary thrift holding company. Its primary business is the operation of its wholly-owned subsidiary, Sterling Bank, through which it offers a range of loan products to the residential and commercial markets, as well as retail banking services. The products and services offered by the bank include saving and current accounts, demand and term deposits, payment cards, trade finance, fund transfer, treasury and cash management. It provides services such as construction loans, residential real estate, commercial real estate, commercial lines of credit and other consumer loans.

Sterling Bancorp Inc

PURPOSE SLVR BULN NN CUR HDG UNT ETF

PURP SLVR BLN USD NN CUR HDG UNT ETF

<p>HC Wainwright &amp; Co.  analyst Edward White   maintains Aura Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AURA#NASDAQ">AURA</a>) with a Buy and raises the price target from $21 to $22.</p>


News

Price Target

Analyst Ratings

AURA

HC Wainwright & Co. Maintains Buy on Aura Biosciences, Raises Price Target to $22

<p>The collaboration supports the licensing of part of Curiosity Stream&#39;s content portfolio in China, Hong Kong, and Macau, bringing 56 unique titles, amounting to 148 hours of premium factual content, to audiences across these territories through various platforms. The deal encompasses a diverse range of programming, from short-form documentary series to premium long-form content.</p>


CURI

Curiosity Inks Strategic Distribution Partnership With Off The Fence; Deal Broadens Company's Footprint Across China, Hong Kong, And Macau

Guidance

CVS's Q3 Results Won't Meet Wall Street's Expectations; Plans To Back Away From Current 2024 Guidance

<p>HC Wainwright &amp; Co.  analyst Heiko Ihle   reiterates DRDGold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRD#NYSE">DRD</a>) with a Buy and maintains $13.25 price target.</p>


Reiteration

HC Wainwright & Co. Reiterates Buy on DRDGold, Maintains $13.25 Price Target

Management

CVS Naming Caremark President David Joyner As Its New CEO

<p>HC Wainwright &amp; Co.  analyst Heiko Ihle   reiterates Avino Silver &amp; Gold Mines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ASM#AMEX">ASM</a>) with a Buy and maintains $1.5 price target.</p>


HC Wainwright & Co. Reiterates Buy on Avino Silver & Gold Mines, Maintains $1.5 Price Target

Biotech

Large Cap

Health Care

General

The European Medicines Agency's Committee For Medicinal Products For Human Use Has Adopted A Positive Opinion, Recommending Approval Of Novo Nordisk's Alhemo (Concizumab) As The First Once-Daily Subcutaneous Prophylactic Treatment For People Aged 12 Years Or Older With Hemophilia A Or B With Inhibitors.

<p>HC Wainwright &amp; Co.  analyst Heiko Ihle   reiterates First Majestic Silver (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AG#NYSE">AG</a>) with a Buy and maintains $8.5 price target.</p>


HC Wainwright & Co. Reiterates Buy on First Majestic Silver, Maintains $8.5 Price Target

<p>The combined companies for the trailing twelve months have generated $235 million in revenue, increasing approximately&nbsp;25%&nbsp;quarter-over-quarter.</p>


BTTR

Better Choice Expects Combined 2025 Pro Forma Basis Revenue And EBITDA To Be Approximately +$270M, And +$10M, Respectively

Better Choice Says Continues To Make Progress Towards Closing Of Its Acquisition Of SRx Health Solutions; Expects Transaction To Close In Late Q4 Of This Year Or Early Q1 Of 2025

<p>Needham  analyst Ami Fadia   reiterates Neumora Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMRA#NASDAQ">NMRA</a>) with a Buy and maintains $23 price target.</p>


NMRA

Needham Reiterates Buy on Neumora Therapeutics, Maintains $23 Price Target

<p>Based on sales trends and order intake in recent years, it expects further market share gains with domestic Chinese OEMs in the coming years.</p>
<p>With the seasonally strong fourth quarter remaining of the year, it reaffirms&nbsp;guidance of around 9.5-10.0% adjusted operating margin for 2024, but to be at the low end of this range.</p>
<p>&nbsp;</p>


Autoliv Now Expects Full Year 2024 Organic Sales Growth To Be 1% Instead Of Previously Expected 2% Due To Unfavorable Market Mix Development

<p>Regions Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RF#NYSE">RF</a>) reported quarterly earnings of $0.57 per share which beat the analyst consensus estimate of $0.53 by 7.55 percent. This is a 16.33 percent increase over earnings of $0.49 per share from the same period last year.  The company reported quarterly sales of $1.87 billion which beat the analyst consensus estimate of $1.80 billion by 3.78 percent.  This is a 0.54 percent increase over sales of $1.86 billion the same period last year.</p>


Earnings

Earnings Beats

Regions Finl Q3 Adj $0.57 Beats $0.53 Estimate, Sales $1.87B Beat $1.80B Estimate

<p>HC Wainwright &amp; Co.  analyst Patrick Trucchio   reiterates Alnylam Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNY#NASDAQ">ALNY</a>) with a Buy and maintains $400 price target.</p>


ALNY

HC Wainwright & Co. Reiterates Buy on Alnylam Pharmaceuticals, Maintains $400 Price Target

<p>Autoliv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALV#NYSE">ALV</a>) reported quarterly earnings of $1.84 per share which missed the analyst consensus estimate of $1.95 by 5.64 percent.  The company reported quarterly sales of $2.56 billion which beat the analyst consensus estimate of $2.53 billion by 0.89 percent.  This is a 1.58 percent decrease over sales of $2.60 billion the same period last year.</p>


Earnings Misses

Autoliv Q3 2024 Adj EPS $1.84 Misses $1.95 Estimate, Sales $2.56B Beat $2.53B Estimate

<p>HC Wainwright &amp; Co.  analyst Amit Dayal   reiterates Gevo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) with a Buy and maintains $14 price target.</p>


GEVO

HC Wainwright & Co. Reiterates Buy on Gevo, Maintains $14 Price Target

<p>Needham  analyst Ami Fadia   reiterates Avadel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVDL#NASDAQ">AVDL</a>) with a Buy and maintains $22 price target.</p>


Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

Needham Reiterates Buy on Avadel Pharmaceuticals, Maintains $22 Price Target

<p>Needham  analyst Mayank Tandon   maintains WNS (Hldgs) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WNS#NYSE">WNS</a>) with a Buy and lowers the price target from $70 to $60.</p>


Needham Maintains Buy on WNS (Hldgs), Lowers Price Target to $60

<p>Needham  analyst Kyle Peterson   reiterates Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Buy and maintains $350 price target.</p>


Needham Reiterates Buy on Equifax, Maintains $350 Price Target

<p>Needham  analyst Mike Matson   downgrades Boston Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) from Buy to Hold and maintains the price target from $86 to $86.</p>


Downgrades

Needham Downgrades Boston Scientific to Hold, Maintains Price Target to $86

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Sterling Bancorp</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/sbt-stock-quote/"><strong>SBT</strong></a></span>) just reported results for the first quarter of 2024.</p><ul><li>The company did not report any EPS for the quarter.</li><li>The company reported revenue of $15.13 million.</li><li>This was 2.12% worse than the analyst estimate for revenue of $15.46 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/earning-results/2024/04/sbt-stock-earnings-sterling-bancorp-for-q1-of-2024/">SBT Stock Earnings: Sterling Bancorp Misses Revenue for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

SBT Stock Earnings: Sterling Bancorp Misses Revenue for Q1 2024

Sterling Bancorp, Inc. (Southfield, MI) (SBT) Q1 2024 Earnings Call Transcript

Warning: SBT is at high risk of performing badly

Sterling Bancorp GAAP EPS of $0.03, revenue of $14.81M

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Sterling Bancorp</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/sbt-stock-quote/"><strong>SBT</strong></a></span>) just reported results for the second quarter of 2024.</p><ul><li>Sterling Bancorp reported earnings per share of 3 cents. This was below the analyst estimate for EPS of 4 cents.</li><li>The company reported revenue of $14.81 million.</li><li>This was 1.88% worse than the analyst estimate for revenue of $15.09 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><p>The post <a href="https://investorplace.com/earning-results/2024/07/sbt-stock-earnings-sterling-bancorp-for-q2-of-2024/">SBT Stock Earnings: Sterling Bancorp Misses EPS, Misses Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

SBT Stock Earnings: Sterling Bancorp Misses EPS, Misses Revenue for Q2 2024

Sterling Bancorp, Inc. (Southfield, MI) (SBT) Q2 2024 Earnings Call Transcript

The latest announcement is out from Sterling Bancorp (SBT). Sterling Bank and Trust has entered into an agreement with CFO Karen Knott, outlining t...

Sterling Bancorp Structures CFO's Termination Compensation Plan

Sterling Bancorp to sell Sterling Bank and Trust, F.S.B to EverBank

The latest announcement is out from Sterling Bancorp ( ($SBT) ). Sterling Bancorp, Inc. has struck a definitive agreement to sell Sterling Bank and...

Sterling Bancorp Announces Sale and Wind-Down Plan

Deals this week: Smartsheet, AT&T, BP, Cleveland-Cliffs, Vistra and more

AXNX

BATL

BLCO

BOOM

CACI

FLUT

INFN

MMSI

OMIC

PLTK

PYTCY

RVNC

SATS

SMAR

STZHF

VVPR

Press Releases

Sterling Bancorp Reports Second Quarter 2024 Financial Results

Sterling Bancorp Announces Sale of Sterling Bank and Trust, F.S.B. to EverBank Financial Corp and Adoption of Plan of Dissolution

SBT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Sterling Bank and Trust, F.S.B. Is Fair to Shareholders

Shareholder Alert: Ademi LLP investigates whether Sterling Bancorp, Inc. has obtained a Fair Price for its Public Shareholders

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Sterling Bancorp, Inc.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MNTX, SBT, ALSA on Behalf of Shareholders

Legal

Kuehn Law Encourages K, MNTX, SBT, and CPTN Investors to Contact Law Firm

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates K, MNTX, SBT, CPTN on Behalf of Shareholders

STERLING BANCORP INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sterling Bancorp, Inc. - SBT

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CBZ, MNTX, SBT on Behalf of Shareholders

ALSA

CPTN

MNTX

Piper Sandler

Comments

Sterling Bancorp

Notizie

Ultime notizie per Sterling Bancorp (NASDAQ:SBT) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO